What does Dr. I. Maurissen, GASTRO-ENTEROLOGIE do?

Dr. I. Maurissen, GASTRO-ENTEROLOGIE is a specialist medical practice in Schoten. Private Limited, started on 16 January 2019, 1 establishment.

What is the address of Dr. I. Maurissen, GASTRO-ENTEROLOGIE?

The registered office of Dr. I. Maurissen, GASTRO-ENTEROLOGIE is located at Koningshoflei 3, 2900 Schoten.

Is Dr. I. Maurissen, GASTRO-ENTEROLOGIE still active?

Yes. According to the CBE (29 October 2026) Dr. I. Maurissen, GASTRO-ENTEROLOGIE is active, legal situation “Normale toestand”, started on 16 January 2019.

Is Dr. I. Maurissen, GASTRO-ENTEROLOGIE registered on Peppol?

Yes, Dr. I. Maurissen, GASTRO-ENTEROLOGIE is registered on the Peppol network with ID 0208:0718739316.

What is the enterprise number of Dr. I. Maurissen, GASTRO-ENTEROLOGIE?

The enterprise number of Dr. I. Maurissen, GASTRO-ENTEROLOGIE is BE0718739316.

When was Dr. I. Maurissen, GASTRO-ENTEROLOGIE founded?

Dr. I. Maurissen, GASTRO-ENTEROLOGIE was founded on 16 January 2019.

Who are the directors of Dr. I. Maurissen, GASTRO-ENTEROLOGIE?

According to the 2025 annual accounts, the directors of Dr. I. Maurissen, GASTRO-ENTEROLOGIE are: Isabelle Maurissen.

Is Dr. I. Maurissen, GASTRO-ENTEROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 January 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. I. Maurissen, GASTRO-ENTEROLOGIE make in 2025?

Dr. I. Maurissen, GASTRO-ENTEROLOGIE posted a profit after taxes of € 142,681 in financial year 2025.

What is the revenue of Dr. I. Maurissen, GASTRO-ENTEROLOGIE?

As a small company, Dr. I. Maurissen, GASTRO-ENTEROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 243,626.

Dr. I. Maurissen, GASTRO-ENTEROLOGIE (Private Limited)

Dossier Dr. I. Maurissen, GASTRO-ENTEROLOGIE, printed on 29 October 2026 from databakkes.be/en/0718739316/dr-i-maurissen-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. I. Maurissen, GASTRO-ENTEROLOGIE from Schoten, company number BE0718739316, closed financial year 2025 with a result of € 142,681 after tax. For that financial year Dr. I. Maurissen, GASTRO-ENTEROLOGIE recorded a gross margin of € 243,626 and equity of € 726,073. Compared with financial year 2024, the result moved from € 131,644 to € 142,681. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.

What it is worth Growing

€ 726,073

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 142,681

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 408,150

▼ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 104,674 paid out

73 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 79,527

▲ € 78,500 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 24,285

▼ 40% vs 2024

€ 16,146 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 7

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,268

▲ 8% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 161,277 Gross margin 2022: € 161,277 First fiscal year in the series	€ 197,385 Gross margin 2023: € 197,385 ▲ 22% vs 2022 (€ 161,277) Favourable step	€ 220,508 Gross margin 2024: € 220,508 ▲ 12% vs 2023 (€ 197,385) Favourable step	€ 243,626 Gross margin 2025: € 243,626 ▲ 10% vs 2024 (€ 220,508) Favourable step	▲ 10%
Profit after taxes	€ 89,527 Profit after taxes 2022: € 89,527 First fiscal year in the series	€ 114,377 Profit after taxes 2023: € 114,377 ▲ 28% vs 2022 (€ 89,527) Favourable step	€ 131,644 Profit after taxes 2024: € 131,644 ▲ 15% vs 2023 (€ 114,377) Favourable step	€ 142,681 Profit after taxes 2025: € 142,681 ▲ 8% vs 2024 (€ 131,644) Favourable step	▲ 8%
Equity	€ 442,045 Equity 2022: € 442,045 First fiscal year in the series	€ 556,422 Equity 2023: € 556,422 ▲ 26% vs 2022 (€ 442,045) Favourable step	€ 688,066 Equity 2024: € 688,066 ▲ 24% vs 2023 (€ 556,422) Favourable step	€ 726,073 Equity 2025: € 726,073 ▲ 6% vs 2024 (€ 688,066) Favourable step	▲ 6%
Total debts	€ 115,562 Total debts 2022: € 115,562 First fiscal year in the series	€ 80,591 Total debts 2023: € 80,591 ▼ 30% vs 2022 (€ 115,562) Favourable step	€ 54,383 Total debts 2024: € 54,383 ▼ 33% vs 2023 (€ 80,591) Favourable step	€ 39,953 Total debts 2025: € 39,953 ▼ 27% vs 2024 (€ 54,383) Favourable step	▼ 27%
Cash	€ 255,418 Cash 2022: € 255,418 First fiscal year in the series	€ 375,001 Cash 2023: € 375,001 ▲ 47% vs 2022 (€ 255,418) Favourable step	€ 423,561 Cash 2024: € 423,561 ▲ 13% vs 2023 (€ 375,001) Favourable step	€ 408,150 Cash 2025: € 408,150 ▼ 4% vs 2024 (€ 423,561) Unfavourable step	▼ 4%
Retained profit	€ 441,445 Retained profit 2022: € 441,445 First fiscal year in the series	€ 555,822 Retained profit 2023: € 555,822 ▲ 26% vs 2022 (€ 441,445) Favourable step	€ 687,466 Retained profit 2024: € 687,466 ▲ 24% vs 2023 (€ 555,822) Favourable step	€ 725,473 Retained profit 2025: € 725,473 ▲ 6% vs 2024 (€ 687,466) Favourable step	▲ 6%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 104,674 Dividend 2025: € 104,674 Unchanged (€ 0) Unchanged
Bank debt	€ 102,587 Bank debt 2022: € 102,587 First fiscal year in the series	€ 63,815 Bank debt 2023: € 63,815 ▼ 38% vs 2022 (€ 102,587) Favourable step	€ 40,256 Bank debt 2024: € 40,256 ▼ 37% vs 2023 (€ 63,815) Favourable step	€ 24,285 Bank debt 2025: € 24,285 ▼ 40% vs 2024 (€ 40,256) Favourable step	▼ 40%
Balance sheet total	€ 557,607 Balance sheet total 2022: € 557,607 First fiscal year in the series	€ 637,013 Balance sheet total 2023: € 637,013 ▲ 14% vs 2022 (€ 557,607) Unchanged	€ 742,449 Balance sheet total 2024: € 742,449 ▲ 17% vs 2023 (€ 637,013) Unchanged	€ 766,026 Balance sheet total 2025: € 766,026 ▲ 3% vs 2024 (€ 742,449) Unchanged	▲ 3%

Key figures of Dr. I. Maurissen, GASTRO-ENTEROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. I. Maurissen, GASTRO-ENTEROLOGIE?

What happened at Dr. I. Maurissen, GASTRO-ENTEROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 10, 2026 New annual accounts for financial year 2025: profit of € 142,681 (▲ 8% vs 2024). Source: NBB ↗
Jan 16, 2019 New establishment in Antwerpen. KBO
Jan 16, 2019 Start of the company according to the CBE. KBO

In short

From € 89,527 profit in 2022 to € 142,681 profit in 2025.

Paid € 197,385 in corporate taxes since 2022.

Best year ever: 2025, with € 142,681 profit.

Paid out € 104,674 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Isabelle Maurissen

Dr. I. Maurissen, GASTRO-ENTEROLOGIE

GASTRO-KLINIEK

Behind Dr. I. Maurissen, GASTRO-ENTEROLOGIE is Isabelle Maurissen. Isabelle Maurissen is also behind GASTRO-KLINIEK.

Directors

According to the 2025 annual accounts

Isabelle Maurissen

Director

Also active at: GASTRO-KLINIEK

Establishments

Establishment units

Physical locations of this company

Registered office

Koningshoflei 3

2900 Schoten

2.284.929.228

Oosterveldlaan 22

2610 Antwerpen

Active since 16 January 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0718.739.316
VAT number: BE 0718.739.316
Registered office: Koningshoflei 3, 2900 Schoten
Names & denominations: Dr. I. Maurissen, GASTRO-ENTEROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 January 2019
Peppol: Active · Active since 18 Feb 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗